✦ LIBER ✦

The management of skin toxicity during erlotinib in advanced non-small cell lung cancer: how much does it cost?

✍ Scribed by Giuliani, Jacopo; Marzola, Marina

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN104 COST-EFFECTIVENESS OF ERLOTINIB I

✍ W Chen; F Sheng; N Qiao 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PCN12 COST EFFECTIVENESS OF ERLOTINIB IN

✍ E Orlewska; A Szczesna; M Gyldmark; M Szkultecka-Debek 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

PCN77 COST-EFFECTIVENESS ANALYSIS OF ERL

✍ TE Ciuleanu; M Dediu; LN Minea; S Baculea; M Szkultecka-Debek 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

12 Use of erlotinib in management of rec

✍ Hameed, H.; Nasim, M.Y.; Dunlop, D.J. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 54 KB

PCN10 COSTS OF MANAGING TOXICITIES IN AD

✍ M Aristides; D Jackson; AM Liepa; NB Leighl; F Shepherd 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

Direct costs associated with the disease

✍ Pompen, Marjolein; Gok, Murat; Novák, Annoesjka; van Wuijtswinkel, Rob; Biesma, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 152 KB